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The Nox oxidases contain NADPH-and FAD-binding sites in the C-terminal cytoplasmic domain and two nonidentical haems in the N-terminal domain composed of six transmembrane α-helices, thereby forming a complete electron transporting system from cytoplasmic NADPH via FAD and the two haems to molecular oxygen on the extracellular side (Sumimoto, 2008) . Nox targeting to the plasma membrane is important for an easy access of ROS to their extracellular targets (e.g., invading microbes in the case of Nox2 and thyroglobulin in the case of Duox2) and for the minimization of intracellular production of often-toxic ROS.
Integral plasma membrane proteins are initially synthesized in the endoplasmic reticulum (ER) and enter the conventional secretory pathway, a selective process that involves formation of cargo-containing coat protein complex II (COPII) vesicles for ER exit and subsequent trafficking via the Golgi apparatus en route to the cell surface (Bonifacino & Glick, 2004; Brandizzi & Barlowe, 2013; Paczkowski, Richardson, & Fromme, 2015) . Budding of COPII-coated transport vesicles on the ER membrane is initiated by activation of the small GTPase Sar1; GTP-bound-Sar1 induces assembly of COPII coat proteins at the ER exit site. Because fission of the COPII vesicle from the ER membrane is triggered by the hydrolysis of GTP to GDP of Sar1 (Bonifacino & Glick, 2004; Brandizzi & Barlowe, 2013; Paczkowski et al., 2015) , the GTPase-deficient mutant Sar1 (H79G) blocks ER exit of cargo proteins in COPII-coated vesicles via the conventional pathway (Hasdemir, Fitzgerald, Prior, Tepikin, & Burgoyne, 2005) . Targeting and fusion of transport vesicles generally depend on the machinery that includes the membrane-bound SNARE proteins, which can function on either transport vesicles (v-SNAREs) or target membranes (t-SNAREs). ER-to-Golgi traffic of COPII vesicles requires syntaxin 5 (Stx5), a t-SNARE protein in the ER-Golgi intermediate compartment (ERGIC), which participates in the fusion of ER-derived COPII vesicles with acceptor ERGIC membranes (Hong & Lev, 2014; Malsam & Söllner, 2011) . Plasma membrane proteins as cargo are subsequently transported from the ERGIC toward the Golgi en route to the cell surface.
Plasma membrane expression via the Sar1/Stx5-dependent (conventional) pathway can be regulated by cargo protein N-glycosylation, a common modification that is initiated in the ER by cotranslational addition of a high mannosecontaining oligosaccharide core to the asparagine residue of the lumenally exposed consensus glycosylation site (AsnXaa-Ser/Thr; Xaa is any amino acid but proline) (Breitling & Aebi, 2013) . As proteins pass via the Golgi, high-mannose oligosaccharides are converted into mature, more complex structure (Stanley, 2011) . The carbohydrate moieties of glycoproteins contribute to protein folding, stability, trafficking and localization within cells. Indeed disruption of the Nglycosylation attenuates cell surface recruitment in various plasma membrane proteins (Conti, Radeke, & Vandenberg, 2002; Glozman et al., 2009; Kelley & Kinsella, 2003; Lichnerova et al., 2015; Rands et al., 1990; Ray, Clapp, Goldsmith, & Spiegel, 1998; Yasuda, Imura, Ishii, Shimizu, & Nakamura, 2015) . Monitoring of the N-glycosylation state of cargo proteins is used to assess the stage in the conventional secretory pathway: A protein with high-mannose oligosaccharides remains retained in the ER, whereas a protein bearing complex oligosaccharides has passed through the Golgi.
The Nox family oxidases are N-glycosylated except Nox5. Nox2 (DeLeo et al., 2000; Yu et al., 1999; Zhu et al., 2006) , Duox1/2 (Grasberger et al., 2012; Morand et al., 2009; Ueyama et al., 2015) and Nox3 (Nakano et al., 2007) are recruited to the cell surface exclusively in the mature, complex N-glycan form, indicating that these glycosylated oxidases advance via the Golgi to the plasma membrane in the conventional secretory pathway. The related oxidase Nox1 reaches the cell surface in two differentially N-glycosylated forms, one complex and one high mannose (Matsumoto et al., 2014; . The high-mannose N-glycanbearing Nox1 protein might be delivered to the plasma membrane without passing via the Golgi. Intriguingly, an N-glycan-deficient mutant Nox1 adequately reaches the cell surface in a fully active state (Matsumoto et al., 2014; . The mechanism for cell surface recruitment of the nonglycosylated Nox1 and the bona fide nonglycoprotein Nox5, however, has remained to be elucidated. It is generally considered that nonglycosylated proteins are transported via the Golgi to the plasma membrane by associating with an N-glycosylated protein partner (subunit), but little is known about the transport pathway for nonglycoproteins without such a partner.
In the present study, we show that the naturally nonglycosylated oxidase Nox5 as well as the nonglycosylated mutants of Nox1 and Nox2 is recruited to the plasma membrane in an unconventional manner: The recruitment is much less sensitive to co-expression of Sar1 (H79G). This is in contrast to wild-type Nox2, which is transported from the ER to the cell surface via the Sar1/Stx5-dependent conventional pathway, similarly to other membrane-integrated glycoproteins such as cystic fibrosis transmembrane conductance regulator (CFTR) (Farinha & Canato, 2017; Wang et al., 2004) , vesicular stomatitis virus glycoprotein (VSVG) (Delisle et al., 2009 ) and β 2 -adrenergic receptor (β 2 -AR) (Wang & Wu, 2012) . However, wild-type Nox1 likely reaches the plasma membrane via both the Sar1/Stx5-dependent and -independent pathways. Interestingly, although Nglycosylated Nox5 mutants reach the plasma membrane mainly as the high-mannose form, they are partly recruited to the cell surface as the complex form in a Sar1-dependent manner. Thus Nox2 and Nox5 are also able to traffic via both the-dependent and -independent pathways. Nox2, which is cotranslationally glycosylated at Asn-132, Asn-149 and Asn-240, forms a complex with the nonglycosylated protein p22 phox in the ER. The Nox2-p22 phox heterodimer reaches the plasma membrane via the Golgi, where Nox2 undergoes sugar chain maturation from the high mannose into complex N-glycans (DeLeo et al., 2000; Yu et al., 1999; Zhu et al., 2006) . Because the mature complex-N-glycan-bearing Nox2 (gp91 phox ), but not its high-mannose glycosylated 65-kDa precursor, is detected on the plasma membrane, this oxidase has been considered to traffic from the ER to the plasma membrane in a conventional manner.
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Cell surface expression of Nox2 as well as CFTR and VSVG. HeLa cells were transfected with pcDNA3-FLAG-Nox2 and pEF-BOS-p22 phox (a), pcDNA3-FLAG-CFTR (b and c), pcDNA3-FLAG-VSVG (d), or pcDNA3-β 2 -AR-FLAG (f); and with pEF-BOS-HA-Sar1
(wt), pEF-BOS-HA-Sar1 (H79G), or pEF-BOS-HA-Stx5. (a) Cell surface recruitment of Nox2. Proteins in the membrane fraction of FLAG-Nox2-expressing cells were labeled by cell surface biotinylation, followed by precipitation with streptavidin-conjugated beads. Precipitants were analyzed by immunoblot with the anti-FLAG or anti-HA antibody. (b and c) N-glycosylation and cell surface recruitment of CFTR. The lysate from HeLa cells expressing FLAG-CFTR was extracted with Triton X-100 and digested with PNGase-F or Endo-H, and proteins were analyzed by immunoblot with the anti-FLAG antibody (b). Cell surface biotinylation of FLAG-CFTR-expressing cells was carried out as described in a, and precipitants were analyzed by immunoblot with the anti-FLAG or anti-HA antibody (c). (d) Cell surface recruitment of VSVG. Cell surface biotinylation of FLAG-VSVG-expressing cells was carried out as described in a, and precipitants were analyzed by immunoblot with the anti-FLAG or anti-HA antibody. (e) Subcellular localization of β 2 -AR. The postnuclear supernatants from β 2 -AR-FLAG-expressing HeLa cells were separated by discontinuous density gradient centrifugation using OptiPrep (10%-20%). After ultracentrifugation, fractions were collected by dripping from the bottom of the tube and analyzed by immunoblot with the anti-FLAG, anti-calnexin (an ER marker), anti-TGN46 (a Golgi marker) or anti-Na + / K + -ATPase α1 subunit (a plasma membrane marker) antibody. (f) Cell surface recruitment of β 2 -AR. Cell surface biotinylation of β 2 -AR-FLAGexpressing cells was carried out as described in a, and precipitants were analyzed by immunoblot with the anti-FLAG or anti-HA antibody. Positions for marker proteins are indicated in kDa Genes to Cells
To clarify whether the conventional secretory pathway is indeed involved in Nox2 trafficking, we expressed Nterminally FLAG-tagged Nox2 (FLAG-Nox2) in HeLa cells and examined the effects of co-expression of Sar1 (H79G), a GTPase-deficient mutant that inhibits the release of COPII-coated vesicles from the ER in the conventional pathway (Aridor, Bannykh, Rowe, & Balch, 1995; Bielli et al., 2005; Delisle et al., 2009; Hasdemir et al., 2005; Zhuang, Chowdhury, Northup, & Ray, 2010) . As shown in Figure 1a , the mature 75-91 kDa form of Nox2 with complex N-glycans disappeared in Sar1 (H79G)-expressing cells, suggesting that Nox2 fails to reach the Golgi. In contrast, Nox2 was normally maturated in cells with co-expression of wild-type Sar1 (wt). Nox2 trafficking to the plasma membrane was also blocked by co-expression of Sar1 (H79G), but not by that of Sar1 (wt), as estimated by cell surface biotinylation (Figure 1a) . Thus Nox2 likely exits the ER as COPII-coated vesicles in a conventional manner.
Because the t-SNARE protein Stx5 is specifically required for the fusion of COPII-coated vesicles with acceptor ERGIC membranes, over-expression of Stx5 is known to efficiently block the conventional ER-to-Golgi transport by disrupting the stoichiometric balance of functional SNARE complexes (Dascher, Matteson, & Balch, 1994; Rowe, Dascher, Bannykh, Plutner, & Balch, 1998; Yoo et al., 2002) . Co-expression of Stx5 severely impaired both maturation and cell surface recruitment of Nox2 (Figure 1a ), supporting the idea that Nox2 is transported in COPII-coated vesicles from the ER to the ERGIC via the conventional pathway.
It is known that CFTR, a membrane-integrated glycoprotein, is usually transported from the ER via the Golgi to the cell surface in a conventional manner (Grasberger et al., 2012; Nakano et al., 2007) . As shown in Figure 1b , FLAG-CFTR existed mainly in an endoglycosidase H (Endo-H)-resistant (mature complex N-glycan) form but not in an Endo-H-sensitive (high-mannose N-glycan) form in HeLa cells. Over-expression of Sar1 (H79G) or Stx5 led to the disappearance of the complex-glycosylated CFTR and the increase in the high-mannose glycosylated one, with a markedly reduced presentation of CFTR on the cell surface ( Figure 1c) . Thus, under the present experimental conditions, CFTR traffics to the plasma membrane via the conventional pathway. Similarly, cell surface targeting of VSVG expressed as a FLAG-tagged protein in HeLa cells was effectively inhibited by over-expression of Sar1 (H79G) and Stx5 ( Figure 1d ). The findings are consistent with previous reports showing that co-expression of Sar1 (H79G) and Stx5 attenuates ER-to-Golgi transport of CFTR and VSVG under different conditions (Aridor et al., 1995; Dascher et al., 1994; Delisle et al., 2009; Gee, Noh, Tang, Kim, & Lee, 2011; Hasdemir et al., 2005; Rowe et al., 1998; Yoo et al., 2002) . The heterotrimeric G protein-coupled receptor β 2 -AR is known to be transported to the plasma membrane via the conventional pathway in a glycosylation-dependent manner (Rands et al., 1990) . Consistent with this, the subcellular fractionation analysis using OptiPrep density gradient centrifugation showed that β 2 -AR reached the plasma membrane (the Na + / K + -ATPase-enriched fraction) exclusively in the complex Nglycan-bearing form (Figure 1e ), and cell surface recruitment of β 2 -AR was effectively blocked by over-expression of Sar1 (H79G) and Stx5 ( Figure 1f ). Thus, the present experimental conditions seem to be suitable for examining the role of the Sar1/Stx5-dependent (conventional) secretory pathway in transmembrane protein trafficking to the plasma membrane.
| Trafficking of Nox5 to the plasma membrane is not prevented by over-expression of Sar1 (H79G) or Stx5
Nox5 is a naturally nonglycosylated transmembrane protein without consensus N-glycosylation sites. Although little is known about the localization of endogenous Nox5 due to the unavailability of specific antibodies with a high sensitivity, previous microscopic analyses have shown that Nox5 localizes predominantly to the ER and also to the plasma membrane, but to a lesser extent, when ectopically expressed in HEK293 cells (Kawahara & Lambeth, 2008; Serrander et al., 2007) . Consistent with these observations, in HeLa cells, N-terminally FLAG-tagged Nox5 (FLAG-Nox5) was colocalized with the ER marker protein calnexin and with Na + /K + -ATPase, a marker of the plasma membrane, as visualized by confocal laser microscopy ( Figure 2a ). Furthermore, subcellular fractionation analysis showed that both untagged Nox5 ( Figure 2b ) and FLAG-Nox5 ( Figure 2c ) is present in the calnexin-enriched ER fraction and in the Na + /K + -ATPase-enriched plasma membrane fraction of HeLa cells, confirming that Nox5 localizes to the plasma membrane as well as to the ER. In addition, intriguingly, Nox5 was also present in fractions 6 and 7 between the ER (fractions 1-5) and the TGN46-enriched Golgi (fractions 8-12) fractions (Figure 2b ,c). In contrast, Nox2 was absent from fractions 6 and 7; the plasma membrane and ER fractions exclusively contained the mature complex-N-glycancarrying Nox2 and its high-mannose glycosylated 65-kDa precursor, respectively ( Figure 2d ). To know the mechanism for trafficking of the bona fide nonglycoprotein Nox5, we investigated the role of Sar1 and Stx5 in cell surface recruitment of Nox5. Over-expression of Sar1 (H79G) and Stx5 in HeLa cells did not prevent presentation of FLAG-Nox5 (Figure 3a ) or untagged Nox5 (Figure 3b ) on the plasma membrane, as estimated by the cell surface biotinylation assay. We also estimated cell surface recruitment of Nox5 by measuring its superoxide-producing activity. It is well known that Nox5 is dormant in resting cells but synergistically activated with the Ca 2+ -ionophore ionomycin and the protein kinase C activator phorbol myristate | Genes to Cells
acetate (PMA) (Chen, Wang, Barman, & Fulton, 2015; Jagnandan et al., 2007) . As shown in Figure 3c , in response to ionomycin and PMA, Nox5 fully produced superoxide even in cells over-expressing Sar1 (H79G) or Stx5. Superoxide appears to be indeed released from the cell surface-expressed Nox5, but not from the one within the cell; this is because superoxide was not detected when superoxide dismutase (SOD), a cell-impermeable superoxide scavenger, was added to the cell suspension. Thus, Nox5 is correctly folded (and thus fully active) at the plasma membrane even under the conditions where the conventional traffic from the ER to the Genes to Cells
plasma membrane is perturbed. In contrast, co-expression of Sar1 (H79G) and Stx5 drastically reduced Nox2-catalyzed superoxide production, which was stimulated with PMA in the presence of the soluble activating proteins p47
phox and Rac (Figure 3d ). This result is consistent with a marked decrease in the amount of Nox2 on the cell surface ( Figure 1a ). Taken together with the present findings, Nox5 is likely transported to the plasma membrane via an unconventional mechanism, which is much less dependent on Sar1 and Stx5.
| Nox1 is partly transported in the high-mannose N-glycan form to the plasma membrane in a manner resistant to over-expression of Sar1 (H79G) or Stx5
Nox1 as well as Nox2 is a glycoprotein (Matsumoto et al., 2014; . Although the mature complex-type glycoform of Nox2, but not the precursor bearing high-mannose type N-glycans, is expressed on the cell surface (Figure 2d ), both high-mannose and complex N-glycan forms of Nox1 are recruited to the plasma membrane in CHO cells ) and HEK293 cells (Matsumoto et al., 2014) . To investigate the mechanism for cell surface recruitment of both forms of Nox1, we expressed Nox1 in HeLa cells and examined the role of the conventional secretion pathway. As shown in Figure 4a , maturation of the Nox1 oligosaccharides from the high mannose to the complex N-glycan form was effectively blocked by over-expression of Sar1 (H79G) and Stx5. Thus, Nox1 is likely delivered from the ER to the plasma membrane at least partly via the Sar1/Stx5-dependent conventional secretion pathway. In contrast to Nox2, substantial amounts of the high-mannose N-glycanbearing Nox1 as well as the complex-glycosylated Nox1 were presented on the cell surface of HeLa cells, as shown by the cell surface biotinylation assay (Figure 4a ). The subcellular fractionation analysis confirmed the presence of both glycan-bearing forms of Nox1 in the plasma membrane (Figure 4b ). Intriguingly, cell surface expression of Nox1 in the high-mannose N-glycan form was not affected by over-expression of Sar1-(H79G) or Stx5 (Figure 4a ), suggesting that a part of Nox1 with high-mannose Nglycans is recruited from the ER to the cell surface in an unconventional manner. Intriguingly, in addition to the ER (fractions 1-5) and the plasma membrane (fractions 13-16), Nox1 was also present in fractions 6 and 7 between the ER and the Golgi (Figure 4b ). Of note, fractions 6 and 7 also contain Nox5 (Figure 2b ,c) but not Nox2 (Figure 2d ) or β 2 -AR (Figure 1e ).
| Glycosylation-defective Nox2 and
Nox1 are recruited to the cell surface even in the presence of Sar1 (H79G)
The present observation that the glycoprotein Nox2 and the nonglycosylated oxidase Nox5 are mainly transported to the plasma membrane via a Sar1/Stx5-dependent and -independent pathway, respectively (Figures 1 and 3) , suggests that N-glycosylation may play a role in the selection of the former pathway. To test this possibility, we simultaneously replaced the three N-glycosylated residues Asn-132, Asn-149 and Asn-240 by a glutamine to construct the nonglycosylated form of Nox2 (N132Q/N149Q/N240Q). As shown in Figure 5a , elimination of N-glycosylation markedly reduced the amount of Nox2 at the protein level. Nevertheless, a small but significant amount of the nonglycosylated Nox2 (N132Q/N149Q/N240Q) was recruited to the cell surface (Figure 5b) . Intriguingly, the recruitment of the mutant protein (Figure 5b ) was less sensitive to co-expression of Sar1 (H79G) than that of wild-type Nox2 (Figure 1a) , suggesting that N-glycosylation promotes the Sar1-dependent Nox2 transport to the plasma membrane.
We have previously reported that an N-glycosylation-sitedeficient mutant Nox1 (N162T/N236T) is fully expressed and normally transported to the cell surface in CHO cells . Consistent with this, another glycosylationdefective mutant Nox1 (N162Q/N236Q) was also effectively recruited to the cell surface in HeLa cells as efficiently as the wild-type protein (Figure 5c ). The recruitment of Nox1 (N162Q/ N236Q) was observed even in the presence of Sar1 (H79G) (Figure 5d ). Thus Nox1 (N162Q/N236Q) is transported to the plasma membrane mainly in a manner resistant to Sar1 (H79G), whereas wild-type Nox1 traffics partly in a Sar1-independent manner but mainly in a Sar1-dependent manner (Figure 4a) . Thus, although nonglycosylated mutants of Nox1 and Nox2 reach the cell surface fully and only marginally, respectively, both advance to the cell surface in a Sar1-independent manner as does the naturally nonglycosylated protein Nox5.
| N-glycosylated mutant Nox5
proteins are partially transported from the ER to the Golgi in a manner sensitive to Sar1 (H79G)
As mentioned above, for cell surface recruitment, Nox1 and Nox2 are able to use both the Sar1-dependent and -independent pathways, the latter of which seems to be preferred by nonglycosylated mutants of Nox1 and Nox2 (Figures 4 and 5) . However, it remained unknown whether Nox5, which mainly traffics in a Sar1 (H79G)-resistant manner (Figure 3) , is also capable of using the Sar1-dependent pathway. To address this question, we introduced an N-glycosylation site into the naturally nonglycosylated oxidase Nox5. The first mutant Nox5 to be N-glycosylated (Nox5*) is constructed by inserting the mouse Nox2 fragment (amino acids 36-45) that contains the N-glycosylation site (Asn40-Tyr41-Thr42) into the corresponding first extracellular loop in human Nox5 (Figure 6a ). In the second mutant Nox5 (Nox5**), the N-glycosylation site (Asn290-Ser291-Thr292) was introduced in the second extracellular loop by the amino acid substitution A290N/P292T (Figure 6a ). When Nox5* or Nox5** was expressed in HeLa cells, these mutant proteins were almost fully N-glycosylated, as indicated by digestion by peptide: N-glycosidase F (PNGase-F) and Endo-H (Figure 6b, upper panel) . A longer exposure of the same blot (Figure 6b, lower panel) showed that a small but significant amount of Nox5* and Nox5** existed as higher F I G U R E 5 Cell surface expression of nonglycosylated Nox2 and Nox1. HeLa cells were transfected with the following plasmids: pcDNA3-FLAG-Nox2 (wt) (a), pcDNA3-FLAG-Nox2 (N132Q/N149Q/N240Q) (a and b), pcDNA3-FLAG-Nox1 (wt) (c), or pcDNA3-FLAG-Nox1 (N162Q/N236Q) (c and d); pEF-BOS-p22 phox ; and with or without pEF-BOS-HA-Sar1 (wt), pEF-BOS-HA-Sar1 (H79G), or pEF-BOS-HA-Stx5. Cell surface biotinylation of FLAG-Nox1-or FLAG-Nox2-expressing cells was carried out as described in Figure 1a , and precipitants were analyzed by immunoblot with the anti-FLAG or anti-HA antibody. Nox2 (NQ) and Nox1 (NQ) indicate Nox2 (N132Q/N149Q/N240Q) and Nox1 (N162Q/N236Q), respectively. Positions for marker proteins are indicated in kDa Genes to Cells KIYOHARA et Al. molecular weight forms on SDS-PAGE. The protein bands with higher molecular weights were sensitive to PNGase-F but resistant to Endo-H, indicating that these Nox5 species contain the complex-type N-glycan. As shown in Figure 6c , the formation of these complex-form mature proteins and their presentation on the plasma membrane were both blocked by co-expression of Sar1 (H79G). Thus, a small but significant part of N-glycosylated Nox5 likely traffics via the Sar1-dependent pathway. In contrast, highmannose-glycosylated Nox5* and Nox5** reached the cell surface even in the presence of Sar1 (H79G) (Figure 6c) , which is consistent with the major role of the Sar1-independent pathway in Nox5 trafficking (Figure 3 ).
| DISCUSSION
In the present study, we show that the membrane-integrated NADPH oxidases Nox1, Nox2 and Nox5 are differentially recruited to the cell surface. Nox2 is transported to the plasma membrane exclusively in the complex N-glycancarrying form via the Sar1/Stx5-mediated (conventional) secretory pathway (Figure 1) . Plasma membrane targeting of the bona fide nonglycoprotein Nox5 is mainly mediated via a distinct (unconventional) mechanism, which is much less dependent on Sar1 and Stx5 (Figure 3) . Thus, Nox2 and Nox5 are mainly transported to the cell surface via the Sar1/Stx5-dependent and -independent pathways, respectively. Nox1 advances to the plasma membrane in complex and high-mannose N-glycan-bearing forms via the Sar1/Stx5-dependent and -independent manner, respectively (Figure 4) . Although the disappearance of the complex N-glycan-carrying Nox1 by over-expression of Sar1 (H79G) or Stx5 indicates not only the involvement of the conventional pathway but also the sufficient inhibition of ER-to-Golgi transport, the high-mannose N-glycanbearing Nox1 effectively traffics to the plasma membrane even in the presence of excess amounts of Sar1 (H79G) or Stx5 (Figure 4 ). These findings indicate that both the Sar1/ Stx5-dependent and -independent pathways substantially participate in Nox1 trafficking.
Intriguingly, similar to the naturally N-glycosylated oxidase Nox1 (Figure 4) , the N-glycosylated mutant Nox5 proteins (Nox5* and Nox5**) are recruited to the plasma membrane in the high-mannose-bearing form and also in the complex N-glycan-carrying form, but to a much lesser extent ( Figure 6 ). The recruitment of Nox5* and Nox5** with high-mannose N-glycans normally occurs in the presence of Sar1 (H79G) (Figure 6 ), which agrees with the major role of the Sar1/Stx5-independent pathway in Nox5 trafficking (Figure 3) . In contrast, Sar1 (H79G) effectively blocks conversion from the high-mannose N-glycans to the complex oligosaccharides in Nox5* and Nox5** (Figure 6 ), indicating that a small but significant part of the mutant proteins is F I G U R E 6 Cell surface expression of glycosylated Nox5. (a) Structure of the glycosylated mutant proteins Nox5* and Nox5**. The sequences of the first and second extracellular loops in Nox5 and Nox2 are aligned; human Nox5 and human/mouse Nox2 comprise 719 and 570 amino acid residues, respectively. In Nox5*, the mouse Nox2 fragment (amino acids 36-45) with the N-glycosylation site is inserted into the first extracellular loop, whereas Nox5** has an N-glycosylation site, which is introduced by amino acid substitution in the second extracellular loop. The consensus sequences for N-glycosylation (N-X-S/T) are underlined. (b) N-glycosylation of the mutant proteins Nox5* and Nox5**. The lysate from HeLa cells expressing Nox5* or Nox5** was extracted with Triton X-100 and digested with PNGase-F or Endo-H, and proteins were analyzed by immunoblot with the anti-FLAG antibody. The lower panel represents a longer exposure of the same blot. (c) Cell surface recruitment of the glycosylated mutant proteins Nox5* and Nox5**. HeLa cells were transfected with pcDNA3-FLAG-Nox5* or pcDNA3-FLAG-Nox5**; and with or without pEF-BOS-HA-Sar1 (H79G). Cell surface biotinylation of FLAG-Nox5-expressing cells was carried out as described in Figure 1a , and precipitants were analyzed by immunoblot with the anti-FLAG or anti-HA antibody. Positions for marker proteins are indicated in kDa | Genes to Cells
transported to the Golgi in a Sar1-dependent manner. Thus, the Sar1-mediated (conventional) pathway also can be used in Nox5 trafficking. The glycosylation-defective mutant Nox2 (N132Q/N149Q/N240Q) is weakly but significantly targeted to the plasma membrane, which occurs even in the presence of Sar1 (H79G) (Figure 5 ). This finding indicates that Nox2, at least in the unglycosylated form, has an ability to use the Sar1-independent pathway for cell surface recruitment, although wild-type Nox2 reaches the plasma membrane exclusively in the complex N-glycan-carrying form via the Sar1/ Stx5-mediated conventional pathway (Figure 1) .
The above-mentioned difference in pathway selection between wild-type and glycosylation-defective Nox2 (Figures 1  and 5) suggests that N-glycosylation may be involved in the selection of the Sar1/Stx5-dependent pathway. This appears to be supported by the finding that plasma membrane recruitment of glycosylation-defective Nox1 ( Figure 5 ) is less sensitive to Sar1 (H79G) than that of wild-type Nox1 (Figure 4) . The selection may also be dependent on types of the cell, because the effect of Sar1 (H79G) on CFTR transport has been reported to be cell type-specific (Yoo et al., 2002) . In addition, the Sar1-independent mechanism may also be launched when the conventional exit from the ER is blocked. In the presence of the conventional ER-exit blocker Sar1 (H79G), small but significant amounts of Nox2 (wt) and CFTR (wt) are recruited to the plasma membrane in the high-mannose N-glycan-carrying form (Figure 1) .
The Sar1 (H79G)-induced cell surface recruitment of high-mannose N-glycan-carrying proteins (Figure 1 ) also suggests that these proteins might bypass the Golgi, which is usually characterized by a lack of complex glycosylation. The Golgi bypass pathway has been reported to be involved in trafficking of several plasma membrane proteins (Grieve & Rabouille, 2011; Rabouille, 2017) ; for example, a mutant CFTR protein with deletion of Phe-508, the most common mutation in cystic fibrosis, fails to rapidly exit the ER but reaches the cell surface by bypassing the Golgi (Gee et al., 2011) . A previous study shows that the voltage-sensitive Kv4 K + channel is likely transported in Sar1-independent non-COPII vesicles from the ER to the Golgi for cell surface recruitment (Hasdemir et al., 2005) . It has been also reported that RNA interference-mediated depletion of both Sar1 isoforms (Sar1A and Sar1B) disrupts COPII assembly but does not severely affect protein secretion via the Golgi (Cutrona et al., 2013) . Thus, the Sar1-independent mechanism for plasma membrane recruitment does not necessarily accompany the Golgi bypass, and ER-to-Golgi transport in the presence and absence of Sar1 function might be mediated via distinct ER-derived vesicles. Among the Nox family oxidases, Nox2 as well as Nox3 forms a tightly associated heterodimer with the nonglycosylated transmembrane protein p22 phox , and the association is required for both stability and plasma membrane transport of each protein: Nox2 and Nox3 are recruited to the cell surface in a manner completely dependent on p22 phox (DeLeo et al., 2000; Nakano et al., 2007; Ueno, Takeya, Miyano, Kikuchi, & Sumimoto, 2005; Yu et al., 1999; Zhu et al., 2006 ). In contrast, Nox1 binds to p22 phox with a lower affinity . In p22 phox -expressing cells, Nox1 traffics to the cell surface in two differentially N-glycosylated forms, one complex and one high mannose (Figure 4 ). In the absence of p22 phox , Nox1 exists exclusively in the high-mannose N-glycan-bearing form, but is still capable of reaching the plasma membrane . Thus, Nox1 by itself appears to have a tendency to unconventionally traffic from the ER to the plasma membrane: The immature, high-mannose N-glycan-bearing Nox1 is able to advance to the cell surface in a Sar1/Stx5-independent manner (Figure 4) . The presence of p22 phox likely allows Nox1 to traffic via the conventional secretory pathway; this is because glycan maturation of Nox1, which depends on p22 phox , is effectively prevented by over-expression of Sar1 (H79G) or Stx5 ( Figure 4 ). These findings suggest that p22 phox as well as Nglycosylation contributes to the selection of the Sar1/Stx5-dependent (conventional) pathway in plasma membrane recruitment of Nox1-Nox3. In contrast to Nox1-Nox3, the bona fide nonglycoprotein Nox5 is incapable of forming a complex with p22 phox (Lambeth, 2004; Sumimoto, 2008) . Consistent with the lack of both N-glycosylation and interaction with p22 phox , the Sar1/Stx5-independent pathway is selected for cell surface recruitment of Nox5 (Figure 3) . Importantly, even in cells over-expressing Sar1 (H79G) or Stx5, the plasma membranepresented Nox5 is correctly folded, as it is fully active in producing superoxide (Figure 3 ). The efficient cell surface targeting of Nox5 likely involves a Nox5-specific N-terminal polybasic region, which can interact with phosphatidylinositol 4,5-bisphosphate, a major phosphoinositide in the plasma membrane (Kawahara & Lambeth, 2008) .
It remains unknown about the molecular basis for the Sar1/Stx5-independent (unconventional) protein recruitment to the plasma membrane. The present subcellular fractionation analysis shows that Nox5, a protein that traffics in a manner resistant to Sar1 inhibition, is localized to fractions devoid of the ER, Golgi and plasma membrane markers (fractions 6 and 7), in addition to the localization to the ER and plasma membrane fractions (Figure 2) . Furthermore, the immature, high-mannose N-glycan-bearing Nox1, but not the one with complex N-glycans, is detected in fractions 6 and 7 (Figure 4) . In contrast, fractions 6 and 7 do not contain Nox2 and β 2 -AR, both of which are transported in a strictly Sar1/Stx5-dependent manner (Figures 1 and 2) . It seems thus possible that these fractions may contain proteins crucial for selection of the dependence. Future studies should be Genes to Cells 
| Plasmid construction
The cDNAs encoding human Nox2 and p22
phox was prepared as previously described (Miyano & Sumimoto, 2012; Takeya et al., 2003) . The cDNA for human Nox5β (amino acids 1-719) (Bánfi et al., 2001 ) was prepared by PCR using a mixture of human testis cDNAs from human multiple tissue cDNA panel I (BD Biosciences) as a template. The cDNA for human Sar1A and Stx5 was prepared by PCR using a mixture of human pancreas cDNAs from human multiple tissue cDNA panel I (BD Biosciences) as a template. The cDNA for human β 2 -AR was prepared by PCR using a mixture of human liver cDNAs from human multiple tissue cDNA panel I (BD Biosciences) as a template. The cDNA for human CFTR was obtained from K.K. DNAFORM (clone ID 100061681). The pEGFP plasmid encoding VSVG, provided by Dr Jennifer Lippincott-Schwartz (Presly et al., 1997) , was purchased from Addgene (Addgene plasmid #11912). Mutations leading to the indicated substitution were introduced by PCRmediated site-directed mutagenesis. All of the constructs were sequenced for confirmation of their identities.
| Cell transfection and immunoblot analysis
HeLa cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), penicillin (100 units/ml) and streptomycin (100 μg/ml) at 37°C under 5% CO 2 . Cells were transfected using X-tremeGENE Transfection Reagent (Roche Applied Science) with the following plasmids: pcDNA3-FLAGNox5; pcDNA3-FLAG-Nox2 plus pEF-BOS-p22 phox ; pcDNA3-FLAG-Nox1 plus pEF-BOS-p22 phox ; pcDNA3-VSVG-FLAG; pcDNA3-FLAG-CFTR; or pcDNA3-β 2 -AR-FLAG. When stated, the cells were cotransfected with pEF-BOS-HA-Sar1 or pEF-BOS-HA-Stx5. Transfected cells were cultured for 24 hr in DMEM containing 10% FBS. For estimation of protein levels, cell lysates were analyzed by immunoblot with the anti-FLAG or anti-HA antibody. The blots were developed using ImmunoStar LD (Wako Pure Chemical Industries) or ImmunoStar Zeta (Wako Pure Chemical Industries) for visualization.
| Glycosidase treatment
Cells expressing FLAG-tagged Nox5, or CFTR was lysed in a solution (150 mM NaCl, and 20 mM Tris-HCl, pH 7.4) containing 1% (w/v) Triton X-100, and the lysate was centrifuged for 10 min at 20,000 × g. The resultant supernatant was subjected to treatment with PNGase-F (New England Biolabs) or Endo-H (New England Biolabs). Proteins were applied to 7% SDS-PAGE, followed by immunoblot analysis with the anti-FLAG antibody.
| Cell surface biotinylation
Cell surface biotinylation was carried out as previously described . HeLa cells in monolayer culture were washed with phosphate-buffered saline (PBS; 137 mM NaCl, 2.68 mM KCl, 8.1 mM Na 2 HPO 4 , and 1.47 mM KH 2 PO 4 , pH 7.4) and treated for 2.5 min at 25°C with 0.5 mM EZ-link Sulfo-NHS-SS-biotin (Pierce), a membrane-impermeable biotinylation reagent, according to the manufacturer's instruction. After the reaction was quenched with 50 mM glycine in PBS, cells were resuspended in PBS containing 1% (v/v) protease inhibitor cocktail (Sigma-Aldrich) and lysed by sonication. The postnuclear fraction of the sonicate was centrifuged for 10 min at 20,000 × g, and the resultant supernatant was ultracentrifuged for 1 hr at 150,000 × g. The pellets were solved in 150 mM NaCl and 20 mM Tris-HCl, pH 7.4, containing 2% (w/v) Triton X-100, and biotinylated membrane proteins were precipitated with streptavidin-Sepharose (GE Healthcare Biosciences). The precipitants were analyzed by immunoblot with the anti-FLAG or anti-Nox5 antibody.
| Superoxide production
HeLa cells were transfected with pcDNA3-FLAG-Nox5; or pcDNA3-FLAG-Nox2, pEF-BOS-p22 phox , pEF-BOSMyc-p67 phox , pEF-BOS-Myc-p47 phox and pEF-BOS-MycRac1 (Q61L) for Nox2-based NADPH oxidase. Transfected cells were cultured for 48 hr and harvested by incubation with trypsin/EDTA for 1 min at 37°C. After being washed with HEPES-buffered saline (120 mM NaCl, 5 mM KCl, 5 mM glucose, 1 mM MgCl 2 , 1 mM CaCl 2 and 17 mM HEPES, pH 7.4) containing 0.04% (w/v) bovine serum albumin (BSA), the cells were suspended in the buffer and tested for estimation of superoxide production. The superoxide-producing activity was determined by SOD-inhibitable chemiluminescence with an enhancer-containing luminol-based detection system (DIOGENES; National Diagnostics), as previously described (Matono, Miyano, Kiyohara, & Sumimoto, 2014; Miyano & Sumimoto, 2012) . After the addition of the enhanced luminol-based substrate, cells were preincubated for 5 min at 37°C, and subsequently stimulated with 5 μM ionomycin and PMA (200 ng/ml) for Nox5 activation or with PMA (200 ng/ml) for Nox2 activation. The chemiluminescence change was monitored 37°C using a luminometer (Auto Lumat LB953, EG&G Berthold).
| Subcellular fractionation
Subcellular fractionation of HeLa cells was carried out using OptiPrep according to the manufacturer's instructions (AxisShield) with minor modifications. HeLa cells in monolayer culture (5 × 10 6 cells) were harvested using a cell scraper and suspended in 330 μl of the homogenization solution: 0.25 mM sucrose, 1 mM EDTA, 1% (v/v) protease inhibitor cocktail (Sigma-Aldrich) and 10 mM HEPES, pH 7.4. Cells were disrupted by three passages through a 27-gauge needle. Nuclei and unbroken cells were pelleted by centrifugation at 1,000 × g for 3 min, followed by collection of the supernatant. The pellet was resuspended in 330 μl of the solution, passed through the needle three times and applied to centrifugation at 1,000 × g for 3 min. After the supernatant was collected, the pellet was once again treated as above. The first, second and third postnuclear supernatants were combined and centrifuged for 10 min at 10,000 × g. The resultant supernatant was loaded on the top of the discontinuous gradient of OptiPrep (Axis-Shield), layering 2.5 ml each of 10% (v/v) and 13%; 0.7 ml each of 14%, 15%, 16%, 17%, 18%, 19% and 20%; and 0.5 ml of 50% of OptiPrep. After ultracentrifugation for 24 hr at 152,000 × g using a RPS40T rotor by the ultracentrifuge Himac CP 65 (Hitachi), sequential 0.7 ml fractions were collected from the bottom of the gradient. For estimation of protein levels of FLAG-Nox5, Nox5, FLAG-Nox2, β 2 -AR-FLAG, and subcellular markers (calnexin) for the ER, TGN46 for the Golgi apparatus and Na 
| Immunofluorescence microscopy
Immunofluorescence microscopy was carried out as previously described Kamakura et al., 2013) . Briefly, HeLa cells were fixed for 20 min in 3.7% formaldehyde and blocked with 0.1% Triton X-100 in PBS containing 3% BSA. Indirect immunofluorescence analysis was carried out using the anti-calnexin, anti-Na + /K + -ATPase α1 subunit and anti-FLAG antibodies with the following secondary antibodies: Alexa Fluor 488-labeled goat anti-rabbit or anti-mouse IgG antibodies (Invitrogen), and Alexa Fluor 594-labeled goat anti-mouse IgG antibodies (Invitrogen). Nuclei were stained with Hoechst 33342 (Invitrogen). Images were taken with the laser-scanning confocal microscope LSM780 (Carl Zeiss).
| Statistical analysis
Statistical differences were analyzed by one-way ANOVA with Tukey-Kramer's multiple comparison of means test.
